|
PSD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50580000024547E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39560000222971E-08 |
| Normal-vs-Stage2 |
1.334570E-01 |
| Normal-vs-Stage3 |
5.10880004966907E-09 |
| Normal-vs-Stage4 |
7.355800E-04 |
| Stage1-vs-Stage2 |
2.835200E-01 |
| Stage1-vs-Stage3 |
1.689750E-01 |
| Stage1-vs-Stage4 |
5.056200E-01 |
| Stage2-vs-Stage3 |
1.399950E-01 |
| Stage2-vs-Stage4 |
5.123400E-01 |
| Stage3-vs-Stage4 |
1.539230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89340000011917E-07 |
| Normal-vs-AfricanAmerican |
1.081180E-03 |
| Normal-vs-Asian |
4.206400E-01 |
| Caucasian-vs-AfricanAmerican |
3.883600E-01 |
| Caucasian-vs-Asian |
2.904600E-01 |
| AfricanAmerican-vs-Asian |
4.143200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35060000000065E-05 |
| Normal-vs-Female |
1.78469999889685E-08 |
| Male-vs-Female |
8.208300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.518200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.2811000000299E-06 |
| Normal-vs-Age(61-80Yrs) |
2.14850004454092E-09 |
| Normal-vs-Age(81-100Yrs) |
2.75690004158946E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.098000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.499760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.892300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.844800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.697100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.936000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.424130E-02 |
| Normal-vs-Grade 2 |
2.04550000271198E-08 |
| Normal-vs-Grade 3 |
6.0647997734975E-10 |
| Normal-vs-Grade 4 |
9.355900E-02 |
| Grade 1-vs-Grade 2 |
7.795200E-01 |
| Grade 1-vs-Grade 3 |
7.869000E-01 |
| Grade 1-vs-Grade 4 |
2.604400E-01 |
| Grade 2-vs-Grade 3 |
9.753200E-01 |
| Grade 2-vs-Grade 4 |
5.406100E-02 |
| Grade 3-vs-Grade 4 |
5.482200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.63153951354889E-13 |
| Normal-vs-ccB subtype |
2.211400E-01 |
| ccA subtype-vs-ccB subtype |
1.8846035843012E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.185870E-04 |
| Normal-vs-N1 |
1.228780E-01 |
| N0-vs-N1 |
5.261600E-01 |
|
|
